Notably, said Merck, the study also showed that treatment with pimicotinib ... Life Sciences service that brings together a ...

Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic ...

"We're excited to achieve the first milestone of our collaboration with Merck and continue our work to improve biologic ... the risk of downturns in demand for products using synthetic biology, (iv) ...

Novel MEK blocker shows promise in rare genetic disorder ...

The European Commission adopted the European Medicines Agency (EMA) recommendation to grant orphan medicinal product designation to VCN-01 for ... Placed second of five finalists for Merck KGaA's EMEA ...

Ginkgo Bioworks Holdings, Inc. , which is building the leading platform for cell programming and biosecurity, today announced its results for the third quarter ended September ...

Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” ...

Bodo Moeller Chemie Japan K.K., officially incorporated on August 23, 2024, will operate from a sales office in Tokyo, with ...

The Cas nuclease market is on an upward trajectory, forecasted to grow from $2.75 billion in 2023 to $3.27 billion in 2024, at a CAGR of 18.9%. Key drivers include the rapid advancements in genome ...

Tbay has become Nigeria's leading app and website for reliable, fast, and secure gift card trading. It has over a million downloads on the Google Play Store and are continuously growing. Known for its ...